Iliac vein stenting appears safe in office-based lab setting

Iliac vein stenting appears safe in office-based lab setting

(HealthDay)—Iliac vein stenting seems safe in an office-based laboratory (OBL) setting, with few major complications and minor complications primarily including insertion site hematomas, according to a study published in the January issue of the Journal of Vascular Surgery: Venous and Lymphatic Disorders.

Ishan Satwah, from the Center for Vascular Medicine in Greenbelt, Maryland, and colleagues prospectively collected data in the Center for Vascular Medicine electronic medical record system and examined the safety profile of iliac vein stenting in an OBL setting. The analysis included patient consultations, interventions, and follow-up at one to six weeks. During the procedure, all patients received moderate sedation.

The researchers found that 1,223 iliac vein stents were placed in 1,104 patients between January 2015 and January 2019. There were 90 minor complications (7.36 percent), mainly insertion site hematomas, and five major complications (0.41 percent), including one allergic reaction, one atrial fibrillation episode, one supraventricular tachycardia episode, one chest pain episode, and one acute stent occlusion. None of the complications were related to sedation or , and none of the patients died.

"In the present study, major complications had occurred in 0.41 percent of our patients. This rate suggests that iliac vein stenting in the OBL setting is safer than stenting procedures performed in the ," the authors write.

More information: Abstract/Full Text

Copyright © 2021 HealthDay. All rights reserved.

Citation: Iliac vein stenting appears safe in office-based lab setting (2022, February 7) retrieved 27 January 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Anatomic compression of iliac vein major factor in pulmonary vascular disease


Feedback to editors